Evergreen Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,420
Closed -$330K 1143
2024
Q4
$330K Buy
+2,420
New +$330K 0.01% 684